iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

In June quarter, Biocon's net profit soars 71% to Rs144 crore

28 Jul 2022 , 07:59 AM

Amid strong growth across all verticals, Biocon, a key player in the biotechnology industry, announced a 71% increase in its consolidated net profit for the June quarter, coming in at Rs144 crore.

In the April through June quarter of the prior fiscal year, the firm reported a net profit of Rs84 crore. In the first quarter, total sales increased to Rs2,217 crore from Rs1,808 crore in the same quarter last year, according to a regulatory filing by Biocon.

Revenues increased, according to Kiran Mazumdar-Shaw, executive chairman of Biocon, as a consequence of the sector’s strong growth in both generics and biosimilars.

Related Tags

  • Biocon
  • economy
  • India
  • news
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.